MAPT and Alzheimer disease: The resulting vasoconstriction is likely to contribute to reduced cerebral blood flow in AD and perhaps also to the neurodegenerative disease process itself, through increased production, accumulation and deposition of Aβ and increased phosphorylation of tau.